CRISPR-Based Diagnostics Entering Clinical Markets

CRISPR based diagnostics entering clinical markets for rapid molecular disease detection

CRISPR-based diagnostics are beginning to enter clinical markets, marking an important transition from research laboratories to real-world healthcare applications. Originally developed as a gene editing technology, CRISPR systems have demonstrated strong potential for detecting genetic material from viruses, bacteria, and human disease biomarkers. These capabilities are drawing attention from biotechnology companies and diagnostic developers seeking … Read more